Clearstead Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.62K | Hold |
3,200
| – | – | ﹤0.01% | 2019 |
|
|
2025
Q1 | $7.04K | Hold |
3,200
| – | – | ﹤0.01% | 1688 |
|
|
2024
Q4 | $4.9K | Hold |
3,200
| – | – | ﹤0.01% | 1719 |
|
|
2024
Q3 | $6.37K | Hold |
3,200
| – | – | ﹤0.01% | 1675 |
|
|
2024
Q2 | $11.2K | Hold |
3,200
| – | – | ﹤0.01% | 1527 |
|
|
2024
Q1 | $9.01K | Hold |
3,200
| – | – | ﹤0.01% | 1069 |
|
|
2023
Q4 | $5.44K | Sell |
3,200
-3,200
| -50% | -$5.44K | ﹤0.01% | 1153 |
|
|
2023
Q3 | $6.59K | Buy |
6,400
+3,200
| +100% | +$3.3K | ﹤0.01% | 1175 |
|
|
2023
Q2 | $3.71K | Buy |
3,200
+1,800
| +129% | +$2.09K | ﹤0.01% | 1078 |
|
|
2023
Q1 | $2.11K | Hold |
1,400
| – | – | ﹤0.01% | 1128 |
|
|
2022
Q4 | $3.5K | Hold |
1,400
| – | – | ﹤0.01% | 1022 |
|
|
2022
Q3 | $6K | Hold |
1,400
| – | – | ﹤0.01% | 950 |
|
|
2022
Q2 | $4K | Hold |
1,400
| – | – | ﹤0.01% | 1027 |
|
|
2022
Q1 | $8K | Hold |
1,400
| – | – | ﹤0.01% | 1014 |
|
|
2021
Q4 | $13K | Hold |
1,400
| – | – | ﹤0.01% | 890 |
|
|
2021
Q3 | $15K | Hold |
1,400
| – | – | ﹤0.01% | 878 |
|
|
2021
Q2 | $22K | Hold |
1,400
| – | – | ﹤0.01% | 692 |
|
|
2021
Q1 | $23K | Hold |
1,400
| – | – | ﹤0.01% | 650 |
|
|
2020
Q4 | $30K | Hold |
1,400
| – | – | ﹤0.01% | 575 |
|
|
2020
Q3 | $21K | Hold |
1,400
| – | – | ﹤0.01% | 578 |
|
|
2020
Q2 | $21K | Hold |
1,400
| – | – | ﹤0.01% | 521 |
|
|
2020
Q1 | $16K | Buy |
+1,400
| New | +$16K | ﹤0.01% | 524 |
|